474 related articles for article (PubMed ID: 30536424)
21. Genetics of Hyperparathyroidism, Including Parathyroid Cancer.
Simonds WF
Endocrinol Metab Clin North Am; 2017 Jun; 46(2):405-418. PubMed ID: 28476229
[TBL] [Abstract][Full Text] [Related]
22. Endocrine neoplasms in familial syndromes of hyperparathyroidism.
Li Y; Simonds WF
Endocr Relat Cancer; 2016 Jun; 23(6):R229-47. PubMed ID: 27207564
[TBL] [Abstract][Full Text] [Related]
23. Absence of somatic RET gene mutation in sporadic parathyroid tumors and hyperplasia secondary to uremia, and absence of somatic Men1 gene mutation in MEN2A-associated hyperplasia.
Uchino S; Noguchi S; Nagatomo M; Sato M; Yamashita H; Yamashita H; Watanabe S; Murakami T; Toda M; Wakiya S; Adachi M
Biomed Pharmacother; 2000 Jun; 54 Suppl 1():100s-103s. PubMed ID: 10915003
[TBL] [Abstract][Full Text] [Related]
24. Genetics of parathyroid tumours.
Thakker RV
J Intern Med; 2016 Dec; 280(6):574-583. PubMed ID: 27306766
[TBL] [Abstract][Full Text] [Related]
25. Molecular genetics of hyperparathyroid disease.
Tominaga Y; Takagi H
Curr Opin Nephrol Hypertens; 1996 Jul; 5(4):336-41. PubMed ID: 8823531
[TBL] [Abstract][Full Text] [Related]
26. Familial isolated primary hyperparathyroidism--a multiple endocrine neoplasia type 1 variant?
Miedlich S; Lohmann T; Schneyer U; Lamesch P; Paschke R
Eur J Endocrinol; 2001 Aug; 145(2):155-60. PubMed ID: 11454510
[TBL] [Abstract][Full Text] [Related]
27. Familial isolated hyperparathyroidism caused by single adenoma: a distinct entity different from multiple endocrine neoplasia.
Watanabe T; Tsukamoto F; Shimizu T; Sugimoto T; Taguchi T; Nishisho I; Nakazawa H; Shiba E; Shishiba Y; Takai S
Endocr J; 1998 Oct; 45(5):637-46. PubMed ID: 10395244
[TBL] [Abstract][Full Text] [Related]
28. Multiple Endocrine Neoplasia and Hyperparathyroid-Jaw Tumor Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood.
Wasserman JD; Tomlinson GE; Druker H; Kamihara J; Kohlmann WK; Kratz CP; Nathanson KL; Pajtler KW; Parareda A; Rednam SP; States LJ; Villani A; Walsh MF; Zelley K; Schiffman JD
Clin Cancer Res; 2017 Jul; 23(13):e123-e132. PubMed ID: 28674121
[TBL] [Abstract][Full Text] [Related]
29. Genetic studies of a family with hereditary hyperparathyroidism-jaw tumour syndrome.
Wassif WS; Farnebo F; Teh BT; Moniz CF; Li FY; Harrison JD; Peters TJ; Larsson C; Harris P
Clin Endocrinol (Oxf); 1999 Feb; 50(2):191-6. PubMed ID: 10396361
[TBL] [Abstract][Full Text] [Related]
30. Management of familial hyperparathyroidism syndromes: MEN1, MEN2, MEN4, HPT-Jaw tumour, Familial isolated hyperparathyroidism, FHH, and neonatal severe hyperparathyroidism.
Cristina EV; Alberto F
Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):861-875. PubMed ID: 30665551
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic challenges due to phenocopies: lessons from Multiple Endocrine Neoplasia type1 (MEN1).
Turner JJ; Christie PT; Pearce SH; Turnpenny PD; Thakker RV
Hum Mutat; 2010 Jan; 31(1):E1089-101. PubMed ID: 19953642
[TBL] [Abstract][Full Text] [Related]
32. Familial Hyperparathyroidism.
Blau JE; Simonds WF
Front Endocrinol (Lausanne); 2021; 12():623667. PubMed ID: 33716975
[TBL] [Abstract][Full Text] [Related]
33. Multiple endocrine neoplasia type 1 and 2: from morphology to molecular pathology 1997.
Komminoth P
Verh Dtsch Ges Pathol; 1997; 81():125-38. PubMed ID: 9474863
[TBL] [Abstract][Full Text] [Related]
34. Lessons from genes mutated in multiple endocrine neoplasia (MEN) syndromes.
Falchetti A; Marini F; Tonelli F; Brandi ML
Ann Endocrinol (Paris); 2005 Jun; 66(3):195-205. PubMed ID: 15988380
[TBL] [Abstract][Full Text] [Related]
35. Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications.
Warner J; Epstein M; Sweet A; Singh D; Burgess J; Stranks S; Hill P; Perry-Keene D; Learoyd D; Robinson B; Birdsey P; Mackenzie E; Teh BT; Prins JB; Cardinal J
J Med Genet; 2004 Mar; 41(3):155-60. PubMed ID: 14985373
[TBL] [Abstract][Full Text] [Related]
36. A MEN1 Patient Presenting With Multiple Parathyroid Adenomas and Transient Hypercortisolism: A Case Report and Literature Review.
Chen F; Xu Q; Yue W; Yu X; Shao S
Front Endocrinol (Lausanne); 2022; 13():802453. PubMed ID: 35370956
[TBL] [Abstract][Full Text] [Related]
37. MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.
Alvelos MI; Vinagre J; Fonseca E; Barbosa E; Teixeira-Gomes J; Sobrinho-Simões M; Soares P
Eur J Endocrinol; 2013 Feb; 168(2):119-28. PubMed ID: 23093699
[TBL] [Abstract][Full Text] [Related]
38. Outcome of Clinical Genetic Testing in Patients with Features Suggestive for Hereditary Predisposition to PTH-Mediated Hypercalcemia.
Khairi S; Osborne J; Jacobs MF; Clines GT; Miller BS; Hughes DT; Else T
Horm Cancer; 2020 Oct; 11(5-6):250-255. PubMed ID: 32761341
[TBL] [Abstract][Full Text] [Related]
39. Genetic and clinical screening for hereditary primary hyperparathyroidism in a large Chinese cohort: a single-center study.
Song A; Yang Y; Jiang Y; Nie M; Jiang Y; Li M; Xia W; Xing X; Wang O
J Bone Miner Res; 2023 Sep; 38(9):1322-1333. PubMed ID: 37449924
[TBL] [Abstract][Full Text] [Related]
40. A contemporary clinical approach to genetic testing for heritable hyperparathyroidism syndromes.
De Sousa SMC; Carroll RW; Henderson A; Burgess J; Clifton-Bligh RJ
Endocrine; 2022 Jan; 75(1):23-32. PubMed ID: 34773560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
